Search Results for: car t

On 15 June 2012, the World Intellectual Property Organization and the Australian Permanent Mission to the World Trade Organization signed an agreement and released a joint communiqué “detailing how an AUD$2 million Australian contribution would assist least-developed and developing countries improve their intellectual property systems”.

Continue Reading →

This statement was delivered by Ecuador on 5 June 2012 at the WTO TRIPS Council on copyright limitations and exceptions.

CONSEJO DE LOS ADPIC
5-6 DE JUNIO DE 2012
PUNTO L. DE LA AGENDA
INTERVENCIÓN DEL ECUADOR

Señor Presidente,

El Ecuador da la bienvenida a la iniciativa organizada por Brasil y Estados Unidos con respecto al punto L. sobre las limitaciones y excepciones a los derechos de autor en el marco de las negociaciones en curso en la OMPI.

Continue Reading →

This statement was delivered by Chile on 5 June 2012 at the WTO TRIPS Council on copyright limitations and exceptions.

AGENDA L COPYRIGHT LIMITATIONS AND EXCEPTIONS

Continue Reading →

At yesterday’s TACD event, USPTO and KEI discussed the report by the Department of Commerce’s Economics and Statistics Administration and the United States Patent and Trademark Office on Intellectual Property and employment. The report, titled: Intellectual Property and the U.S. Economy: Industries in Focus, has been widely quoted, including these bullets from its executive summary:

• IP-intensive industries accounted for about $5.06 trillion in value added, or 34.8 percent of U.S. gross domestic product (GDP), in 2010.

Continue Reading →

On 5 June 2012, India delivered the following intervention at the WTO Council for TRIPS on agenda item K, “Exchange of information on securing supply chains against counterfeit goods”.

Intervention on Agenda Item K

Continue Reading →

In preparation for the 65th World Health Assembly, held in Geneva from 21 May 2012 to 26 May 2012, the World Health Organization (WHO) prepared a document (A65/29 Add. 1, 5 April 2012) entitled “Voluntary contributions by fund and by donor for the financial period 2010-2011. Continue Reading →

This is a rough list of the recent ICE press releases mentioning counterfeit and pharmaceutical. It is quite clear that the overwhelming majority of counterfeit busts involve Viagra and other erectile dysfunction drugs, a problem that will probably resolve itself once the Pfizer patents on Viagra expire.

In my quick read of the ICE press releases, I found just 12 pharmaceutical counterfeiting cases in the ICE press releases from 2009 to May 2012, with 14 defendants.

• 13 of the 14 defendants were men.

Continue Reading →

Donald McNeil has an article in the New York Times that appeared in print on May 22, 2012 (page D6 of the New York edition) with the headline: “Malaria: Fake and Substandard Drugs Grow as Threat to Fight Disease.” A web version is available here: http://www.nytimes.com/2012/05/22/health/policy/fake-and-substandard-drugs-grow-as-threat-to-fight-malaria.html

Continue Reading →